CAR chasing: Canine adenovirus vectors - All bite and no bark?

Journal of Gene Medicine

Volumn 6, Issue SUPPL. 1, 2004, Pages

  Kremer, Eric J ^a  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

Canine adenovirus vectors; CAR; Gene therapy; Neurodegenerative diseases; Neuronal tropism; Retrograde transport; Vaccines

Indexed keywords

ADENOVIRUS VECTOR; CANCER VACCINE; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; E1A PROTEIN; LYSOSOME ENZYME; OSTEOCALCIN; VIRUS VACCINE; ADENOVIRUS TYPE 2 VACCINE (CANINE); ADENOVIRUS TYPE-2 VACCINE (CANINE); HEPATITIS VACCINE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CANCER THERAPY; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; GENE TRANSFER; HUMAN; HUMORAL IMMUNITY; HUNTINGTON CHOREA; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LYSOSOME STORAGE DISEASE; NERVE FIBER; NONHUMAN; OSTEOSARCOMA; PARKINSON DISEASE; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS TITRATION; ADENOVIRUS; ANIMAL; DOG; GENE THERAPY; GENE VECTOR; GENETICS; IMMUNOLOGY; MOUSE; REPORTER GENE;

ADENOVIRIDAE; CANINE ADENOVIRUS; CHICKEN ANEMIA VIRUS;

ADENOVIRUSES, CANINE; ANIMALS; DOGS; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; HUMANS; MICE; NEURODEGENERATIVE DISEASES; VIRAL HEPATITIS VACCINES;

EID: 4644353743     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.497     Document Type: Review

References (164)

1. Akli S, Caillaud C, Vigne E, et al. Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet 1993; 3: 224-228.
2. Albinsson B, Kidd AH. Adenovirus type 41 lacks an RGD alpha(v)-integrin binding motif on the penton base and undergoes delayed uptake in A549 cells. Virus Res 1999; 64: 125-136.
3. Amalfitano A, Parks RJ. Separating fact from fiction: assessing the potential of modified adenovirus vectors for use in human gene therapy. Curr Gene Ther 2002; 2: 111-133.
4. Appay V, Zaunders JJ, Papagno L, et al. Characterization of CD4(+) CTLs ex vivo. J Immunol 2002; 168: 5954-5958.
5. Bai M, Harfe B, Freimuth P. Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells. J Virol 1993; 67: 5198-5205.
6. Beal MF. Experimental models of Parkinson's disease. Nat Rev Neurosci 2001; 2: 325-334.
7. Bearer EL, Breakefield XO, Schuback D, Reese TS, LaVail JH. Retrograde axonal transport of herpes simplex virus: evidence for a single mechanism and a role for tegument. Proc Natl Acad Sci U S A 2000; 97: 8146-8150.
8. Benihoud K, Yeh P, Perricaudet M. Adenovirus vectors for gene delivery. Curr Opin Biotechnol 1999; 10: 440-447.
9. Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323.
10. Bergelson JM, Krithivas A, Celi L, et al. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J Virol 1998; 72: 415-419.
11. Bewley MC, Springer K, Zhang YB, Freimuth P, Flanagan JM. Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. Science 1999; 286: 1579-1583.
12. Bhat N, Fan F. Adenovirus infection induces microglial activation: involvement of mitogen-activated protein kinase pathways. Brain Res 2002; 948: 93.
13. Bjorklund A, Kirik D, Rosenblad C, Georgievska B, Lundberg C, Mandel RJ. Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model(1). Brain Res 2000; 886: 82-98.
14. Blomer U, Naldini L, Kafri T, Trono D, Verma IM, Gage FH. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 1997; 71: 6641-6649.
15. Bosch A, Perret E, Desmaris N, Heard JM. Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors. Mol Ther 2000; 1 63-70.
16. Bosch A, Perret E, Desmaris N, Trono D, Heard JM. Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer. Hum Gene Ther 2000; 11 1139-1150.
17. Both GW. Xenogenic adenoviruses. In Adenoviral vectors for gene therapy, Curiel D, Douglas J (eds). Academic Press: San Diego, 2002; 447-479.
18. Brooks AI, Stein CS, Hughes SM, et al. Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors. Proc Natl Acad Sci U S A 2002; 99: 6216-6221.
19. Cabrera-Salazar MA, Novelli E, Barranger JA. Gene therapy for the lysosomal storage disorders. Curr Opin Mol Ther 2002; 4: 349-358.
20. Callahan CA, Yoshikawa S, Thomas JB. Tracing axons. Curr Opin Neurobiol 1998; 8: 582-586.
21. Chardonnet Y, Dales S. Early events in the interaction of adenoviruses with HeLa cells. I. Penetration of type 5 and intracellular release of the DNA genome. Virology 1970; 40: 462-477.
22. Chardonnet Y, Dales S. Early events in the interaction of adenoviruses with HeLa cells. II. Comparative observations on the penetration of types 1, 5, 7, and 12. Virology 1970; 40: 478-485.
23. Chartier C, Degryse E, Gantzer M, Dieterle A, Pavirani A, Mehtali M. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 1996; 70 4805-4810.
24. Chen H, McCarty DM, Bruce AT, Suzuki K. Oligodendrocyte-specific gene expression in mouse brain: use of a myelin-forming cell type-specific promoter in an adeno-associated virus. J Neurosci Res 1999; 55: 504-513.
25. Chillon M, Kremer EJ. Trafficking and propagation of canine adenovirus vectors lacking a known integrin-interacting motif. Hum Gene Ther 2001; 12: 1815-1823.
26. Chiocca S, Kurzbauer R, Schaffner G, Baker A, Mautner V, Cotten M. The complete DNA sequence and genomic organization of the avian adenovirus CELO. J Virol 1996; 70: 2939-2949.
27. Chiu CY, Mathias P, Nemerow GR, Stewart PL. Structure of adenovirus complexed with its internalization receptor, alphavbeta5 integrin. J Virol 1999; 73: 6759-6768.
28. Cohen CJ, Xiang ZQ, Gao GP, Ertl HC, Wilson JM, Bergelson JM. Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor. J Gen Virol 2002; 83: 151-155.
29. Cornwell HJ, Koptopoulos G, Thompson H, McCandlish IA, Wright NG. Immunity to canine adenovirus respiratory disease: a comparison of attenuated CAV-1 and CAV-2 vaccines. Vet Rec 1982; 110: 27-32.
30. Crystal RG. The gene as the drug. Nat Med 1995; 1 15-17.
31. D'Ambrosio E, Del Grosso N, Chicca A, Midulla M. Neutralizing antibodies against 33 human adenoviruses in normal children in Rome. J Hyg (Lond) 1982; 89: 155-161.
32. Davidson BL, Stein CS, Heth JA, et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci U S A 2000; 97: 3428-3432.
33. Davies JC. New therapeutic approaches for cystic fibrosis lung disease. J R Soc Med 2002; 95: Suppl 41: 58-67.
34. Davison E, Diaz RM, Hart IR, Santis G, Marshall JF. Integrin alpha5beta1-mediated adenovirus infection is enhanced by the integrin-activating antibody TS2/16. J Virol 1997; 71: 6204-6207.
35. Descamps V, Blumenfeld N, Villeval JL, Vainchenker W, Perricaudet M, Beuzard Y. Erythropoietin gene transfer and expression in adult normal mice: use of an adenovirus vector. Hum Gene Ther 1994; 5: 979-985.
36. Fallaux FJ, Bout A, van der Velde I, et al. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther 1998; 9: 1909-1917.
37. Fallaux FJ, Kranenburg O, Cramer SJ, et al. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther 1996; 7: 215-222.
38. Fallaux FJ, van der Eb AJ, Hoeben RC. Who's afraid of replication-competent adenoviruses? Gene Ther 1999; 6: 709-712.
39. Farina SF, Gao GP, Xiang ZQ, et al. Replication-defective vector based on a chimpanzee adenovirus. J Virol 2001; 75: 11 603-11 613.
40. Fechner H, Haack A, Wang H, et al. Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Ther 1999; 6: 1520-1535.
41. Fejer G, Berencsi G, Ruzsics Z, Belak S, Linne T, Nasz I. Multiple enlargements in the right inverted terminal repeat of the DNA of canine adenovirus type 2. Acta Microbiol Hung 1992; 39: 159-168.
42. Flomenberg P, Piaskowski V, Truitt RL, Casper JT. Characterization of human proliferative T cell responses to adenovirus. J Infect Dis 1995; 171: 1090-1096.
43. Flotte TR. Gene therapy for cystic fibrosis. Curr Opin Mol Ther 1999; 1: 510-516.
44. Ghodsi A, Stein C, Derksen T, Yang G, Anderson RD, Davidson BL. Extensive beta-glucuronidase activity in murine central nervous system after adenovirus-mediated gene transfer to brain. Hum Gene Ther 1998; 9: 2331-2340.
45. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 59-74.
46. Greber UF. Signalling in viral entry. Cell Mol Life Sci 2002; 59: 608-626.
47. Griesenbach U, Ferrari S, Geddes DM, Alton EW. Gene therapy fibrosis. Gene Ther 2002; 9: 1344-1350.
48. Hamelin C, Jouvenne P, Assaf R. Genotypic characterization of type-2 variants of canine adenovirus. Am J Vet Res 1986; 47: 625-630.
49. Hanahan D. Studies on transformation of Escherichia coli with plasmids. J Mol Biol 1983; 166: 557-580.
50. Harvey BG, Worgall S, Ely S, Leopold PL, Crystal RG. Cellular immune responses of healthy individuals to intradermal administration of an E1-E3-adenovirus gene transfer vector. Hum Gene Ther 1999; 10 2823-2837.
51. Hehir KM, Armentano D, Cardoza LM, et al. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence. J Virol 1996; 70: 8459-8467.
52. Hemmi S, Geertsen R, Mezzacasa A, Peter I, Dummer R. The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. Hum Gene Ther 1998; 9: 2363-2673.
53. Hemminki A, Kanerva A, Kremer EJ, et al. A canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal model. Mol Ther 2003; 7: 163-173.
54. Hess M, Cuzange A, Ruigrok RW, Chroboczek J, Jacrot B. The avian adenovirus penton: two fibres and one base. J Mol Biol 1995; 252: 379-385.
55. Hofmann C, Loser P, Cichon G, Arnold W, Both GW, Strauss M. Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo. J Virol 1999; 73: 6930-6936.
56. Hong SS, Boulanger P. Protein ligands of the human adenovirus type 2 outer capsid identified by biospanning of a phage-displayed peptide library on separate domains of wild-type and mutant penton capsomers. EMBO J 1995; 14: 4714-4727.
57. Hong SS, Karayan L, Tournier J, Curiel DT, Boulanger PA. Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J 1997; 16: 2294-2306.
58. Horwitz M. Adenoviruses. In Field's Virology, Fields B, Knipe D (eds). Raven Press: Philadelphia, 1996; 2149-2171.
59. Hsia S, Howell DN, Amos DB, Woodbury MA. Studies of viral antibody responses among Amish families. J Immunol 1977; 118: 1659-1664.
60. Huang S, Kamata T, Takada Y, Ruggeri ZM, Nemerow GR. Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J Virol 1996; 70: 4502-4508.
61. Hynes RO. Specificity of cell adhesion in development: the cadherin superfamily. Curr Opin Genet Dev 1992; 2: 621-624.
62. Jooss K, Yang Y, Fisher KJ, Wilson JM. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J Virol 1998; 72: 4212-4223.
63. Kaplitt MG, Leone P, Samulski RJ, et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994; 8: 148-154.
64. Khuri FR, Nemunaitis J, Ganly I, et al. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med 2000; 6: 879-885.
65. Kirby I, Davison E, Beavil AJ, et al. Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein. J Virol 2000; 74: 2804-2813.
66. Kissa K, Mordelet E, Soudais C, et al. In vivo neuronal tracing with GFP-TTC gene delivery. Mol Cell Neurosci 2002; 20 627.
67. Klonjkowski B, Gilardi-Hebenstreit P, Hadchouel J, et al. A recombinant E1-deleted canine adenoviral vector capable of transduction and expression of a transgene in human-derived cells and in vivo. Hum Gene Ther 1997; 8: 2103-2115.
68. Kochanek S, Clemens PR, Mitani K, Chen HH, Chan S, Caskey CT. A new adenoviral vector: replacement of all viral coding sequences with 28kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc Natl Acad Sci U S A 1996; 93: 5731-5736.
69. Kremer EJ, Boutin S, Chillon M, Danos O. Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer. J Virol 2000; 74: 505-512.
70. Kremer EJ, Perricaudet M. Adenovirus and adeno-associated virus mediated gene transfer. Br Med Bull 1995; 51: 31-44.
71. Kruyt FA, Curiel DT. Toward a new generation of conditionally replicating adenoviruses: pairing tumor selectivity with maximal oncolysis. Hum Gene Ther 2002; 13: 485-495.
72. Le Gal La Salle G, Robert JJ, Berrard S, et al. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 1993; 259: 988-990.
73. Levi S, Chesnoy-Marchais D, Sieghart W, Triller A. Synaptic control of glycine and GABA(A) receptors and gephyrin expression in cultured motoneurons. J Neurosci 1999; 19: 7434-7449.
74. Lewis JM, Cheresh DA, Schwartz MA. Protein kinase C regulates alpha v beta 5-dependent cytoskeletal associations and focal adhesion kinase phosphorylation. J Cell Biol 1996; 134: 1323-1332.
75. Li E, Brown SL, Stupack DG, Puente XS, Cheresh DA, Nemerow GR. Integrin alphavbeta1 is an adenovirus coreceptor. J Virol 2001; 75: 5405-5409.
76. Li E, Stupack D, Bokoch GM, Nemerow GR. Adenovirus endocytosis requires actin cytoskeleton reorganization mediated by Rho family GTPases. J Virol 1998; 72: 8806-8812.
77. Li E, Stupack DG, Brown SL, Klemke R, Schlaepfer DD, Nemerow GR. Association of p130CAS with phosphatidylinositol-3-OH kinase mediates adenovirus cell entry. J Biol Chem 2000; 275: 14 729-14 735.
78. Liebermann H, Lotz K, Mentel R, Bauer U, Seidel W. Mapping of linear epitopes on fibre knob of human adenovirus serotype 5. Virus Res 2001; 73: 145-151.
79. Liebermann H, Lotz K, Seidel W. Mapping of epitopes on the fiber knobs of human adenovirus serotypes 8 and 15. Intervirology 2002; 45: 59-66.
80. Liebermann H, Mentel R, Bauer U, et al. Receptor binding sites and antigenic epitopes on the fiber knob of human adenovirus serotype 3. J Virol 1998; 72: 9121-9230.
81. Lilley CE, Branston RH, Coffin RS. Herpes simplex virus vectors for the nervous system. Curr Gene Ther 2001; 1: 339-358.
82. Lilley CE, Groutsi F, Han Z, et al. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo. J Virol 2001; 75 4343-4356.
83. Loser P, Hillgenberg M, Arnold W, Both GW, Hofmann C. Ovine adenovirus vectors mediate efficient gene transfer to skeletal muscle. Gene Ther 2000; 7: 1491-1498.
84. Loser P, Huser A, Hillgenberg M, Kumin D, Both GW, Hofmann C. Advances in the development of non-human viral DNA-vectors for gene delivery. Curr Gene Ther 2002; 2: 161-171.
85. Mahr JA, Gooding LR. Immune evasion by adenoviruses. Immunol Rev 1999; 168: 121-130.
86. Maizel JV, White DO, Scharff MD. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology 1968; 36: 115-125.
87. Mandel RJ, Spratt SK, Snyder RO, Leff SE. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc Natl Acad Sci U S A 1997; 94: 14 083-14 088.
88. Matzinger P. An innate sense of danger. Ann N Y Acad Sci 2002; 961: 341-342.
89. McCown TJ, Xiao X, Li J, Breese GR, Samulski RJ. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res 1996; 713: 99-107.
90. McElvaney NG, Crystal RG. IL-6 release and airway administration of human CFR cDNA adenovirus vector. Nat Med 1995; 1: 182-184.
91. Meier O, Boucke K, Hammer SV, et al. Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J Cell Biol 2002; 158: 1119-1131.
92. Mi J, Chatterjee S, Wong KK, Forbes C, Lawless G, Tobin AJ. Recombinant adeno-associated virus (AAV) drives constitutive production of glutamate decarboxylase in neural cell lines. J Neurosci Res 1999; 57: 137-148.
93. Michou AI, Lehrmann H, Saltik M, Cotten M. Mutational analysis of the avian adenovirus CELO, which provides a basis for gene delivery vectors. J Virol 1999; 73: 1399-1410.
94. Mittal SK, Middleton DM, Tikoo SK, Prevec L, Graham FL, Babiuk LA. Pathology and immunogenicity in the cotton rat (Sigmodon hispidus) model after infection with a bovine adenovirus type 3 recombinant virus expressing the firefly luciferase gene. J Gen Virol 1996; 77: 1-9.
95. Mittal SK, Prevec L, Graham FL, Babiuk LA. Development of a bovine adenovirus type 3-based expression vector. J Gen Virol 1995; 76: 93-102.
96. Mittereder N, March KL, Trapnell BC. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 1996; 70: 7498-7509.
97. Morsy MA, Caskey CT. Expanded-capacity adenoviral vectors - the helper-dependent vectors. Mol Med Today 1999; 5: 18-24.
98. Morsy MA, Gu M, Motzel S, et al. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc Natl Acad Sci U S A 1998; 95: 7866-7871.
99. Moullier P, Bohl D, Heard JM, Danos O. Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts. Nat Genet 1993; 4: 154-159.
100. Nakashima T, Kimmelman CP, Snow JB Jr. Olfactory marker protein in the human olfactory pathway. Arch Otolaryngol 1985; 111: 294-297.
101. Nalbantoglu J, Pari G, Karpati G, Holland PC. Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells. Hum Gene Ther 1999; 10: 1009-1019.
102. Nemerow GR. Adenoviral vectors-new insights. Trends Microbiol 2000; 8: 391-394.
103. Nemerow GR, Stewart PL. Role of alpha(v) integrins in adenovirus cell entry and gene delivery. Microbiol Mol Biol Rev 1999; 63: 725-734.
104. Nemunaitis J, Khuri F, Ganly I, et al. Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer. J Clin Oncol 2001; 19: 289-298.
105. Nobes CD, Hall A. Rho, rac and cdc42 GTPases: regulators of actin structures, cell adhesion and motility. Biochem Soc Trans 1995; 23: 456-459.
106. Norrby E, Wadell G. Immunological relationships between hexons of certain human adenoviruses. J Virol 1969; 4: 663-670.
107. Olive M, Eisenlohr L, Flomenberg N, Hsu S, Flomenberg P. The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope. Hum Gene Ther 2002; 13: 1167-1178.
108. Olive M, Eisenlohr LC, Flomenberg P. Quantitative analysis of adenovirus-specific CD4+ T-cell responses from healthy adults. Viral Immunol 2001; 14: 403-413.
109. Onodera M, Nelson DM, Sakiyama Y, Candotti F, Blaese RM. Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: improved retroviral vectors for clinical trials. Acta Haematol 1999; 101: 89-96.
110. Paillard F. Advantages of non-human adenoviruses versus human adenoviruses. Hum Gene Ther 1997; 8: 2007-2009.
111. Palmer JA, Branston RH, Lilley CE, et al. Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system. J Virol 2000; 74 5604-5618.
112. Parks RJ, Chen L, Anton M, Sankar U, Rudnicki MA, Graham FL. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci U S A 1996; 93: 13 565-13 570.
113. Parsons JT. Integrin-mediated signalling: regulation by protein tyrosine kinases and small GTP-binding proteins. Curr Opin Cell Biol 1996; 8: 146-152.
114. Piedra PA, Poveda GA, Ramsey B, McCoy K, Hiatt PW. Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors. Pediatrics 1998; 101: 1013-1019.
115. Rasmussen UB, Benchaibi M, Meyer V, Schlesinger Y, Schughart K. Novel human gene transfer vectors: evaluation of wild-type and recombinant animal adenoviruses in human-derived cells. Hum Gene Ther 1999; 10: 2587-2599.
116. Rasmussen UB, Schlesinger Y, Pavirani A, Mehtali M. Sequence analysis of the canine adenovirus 2 fiber-encoding gene. Gene 1995; 159: 279-280.
117. Roelvink PW, Lizonova A, Lee JG, et al. The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol 1998; 72: 7909-7915.
118. Roelvink PW, Mi Lee G, Einfeld DA, Kovesdi I, Wickham TJ. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. Science 1999; 286: 1568-1571.
119. Ross D, Ziff E. Defective processing of human adenovirus 2 late transcription unit mRNAs during abortive infections in monkey cells. Virology 1994; 202: 107-115.
120. Ross D, Ziff E. Defective synthesis of early region 4 mRNAs during abortive adenovirus infections in monkey cells. J Virol 1992; 66: 3110-3117.
121. Russell WC. Update on adenovirus and its vectors. J Gen Virol 2000; 81: 2573-2604.
122. Schell K, Rhim JS, Turner HC, Huebner RJ. Adenovirus T antigen: production by abortive infection of rabbit kidney cells. Proc Soc Exp Biol Med 1968; 128: 922-928.
123. Schiedner G, Morral N, Parks RJ, et al. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 1998; 18 180-183.
124. Sester M, Sester U, Salvador SA, et al. Age-related decrease in adenovirus-specific T cell responses. J Infect Dis 2002; 185: 1379-1387.
125. Shaw G, Morse S, Ararat M, Graham FL. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 2002; 16: 869-871.
126. Shenk T. Adenoviridae: the viruses and their replication. In Field's Virology (3rd edn). Fields B, Knipe D (eds). Raven Press: Philadelphia, 1996; 2111-2148.
127. Sinnayah P, Lindley TE, Staber PD, Cassell MD, Davidson BL, Davisson RL. Selective gene transfer to key cardiovascular regions of the brain: comparison of two viral vector systems. Hypertension 2002; 39: 603-608.
128. Sonderbye L, Feng S, Yacoubian S, et al. In vivo and in vitro modulation of immune stimulatory capacity of primary dendritic cells by adenovirus-mediated gene transduction. Exp Clin Immunogenet 1998; 15: 100-111.
129. Sonnenberg A. Integrins and their ligands. Curr Top Microbiol Immunol 1993; 184: 7-35.
130. Soudais C, Boutin S, Hong SS, et al. Canine adenovirus type 2 attachment and internalization: coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway. J Virol 2000; 74: 10 639-10 649.
131. Soudais C, Boutin S, Kremer EJ. Characterisation of cis-acting sequences involved in the canine adenovirus packaging domain. Mol Ther 2001; 3: 631-640.
132. Soudais C, Laplace-Builhe C, Kissa K, Kremer EJ. Preferential transduction of neurons by canine adenovirus vectors and their efficient retrograde transport in vivo. FASEB J 2001; 15: 2283-2285.
133. Soudais C, Skander N, Kremer E. Long-term in vivo transduction of neurons throughout the rat CNS using novel helper-dependent CAV-2 vectors. FASEB J 2004; in press.
134. Stein CS, Ghodsi A, Derksen T, Davidson BL. Systemic and central nervous system correction of lysosomal storage in mucopolysaccharidosis type VII mice. J Virol 1999; 73: 3424-3429.
135. Stein CS, Kang Y, Sauter SL, et al. In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors. Mol Ther 2001; 3: 850-856.
136. Stewart PL, Chiu CY, Huang S, et al. Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization. EMBO J 1997; 16: 1189-1198.
137. Stitz J, Muhlebach MD, Blomer U, et al. A novel lentivirus vector derived from apathogenic simian immunodeficiency virus. Virology 2001; 291: 191-197.
138. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 1992; 90: 626-630.
139. Suomalainen M, Nakano MY, Boucke K, Keller S, Greber UF. Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus. EMBO J 2001; 20: 1310-1319.
140. Thomas CE, Schiedner G, Kochanek S, Castro MG, Lowenstein PR. Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chronic diseases. Proc Natl Acad Sci U S A 2000; 97: 7482-7487.
141. Tibbles LA, Spurrell JC, Bowen GP, et al. Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10. J Virol 2002; 76: 1559-1568.
142. Tiemessen CT, Kidd AH. Adenovirus type 40 and 41 growth in vitro: host range diversity reflected by differences in patterns of DNA replication. J Virol 1994; 68: 1239-1244.
143. Tomko RP, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A 1997; 94: 3352-3356.
144. Torres JM, Alonso C, Ortega A, Mittal S, Graham F, Enjuanes L. Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus. J Virol 1996; 70: 3770-3780.
145. van Raaij MJ, Chouin E, van der Zandt H, Bergelson JM, Cusack S. Dimeric structure of the coxsackievirus and adenovirus receptor D1 domain at 1.7 A resolution. Structure Fold Des 2000; 8: 1147-1155.
146. van Raaij MJ, Mitraki A, Lavigne G, Cusack S. A triple beta-spiral in the adenovirus fibre shaft reveals a new structural motif for a fibrous protein. Nature 1999; 401: 935-938.
147. Wadell G. Sensitization and neutralization of adenovirus by specific sera against capsid subunits. J Immunol 1972; 108: 622-632.
148. Walters RW, Freimuth P, Moninger TO, Ganske I, Zabner J, Welsh MJ. Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape. Cell 2002; 110: 789-799.
149. Wang X, Bergelson JM. Coxsackievirus and adenovirus receptor cytoplasmic and transmembrane domains are not essential for coxsackievirus and adenovirus infection. J Virol 1999; 73: 2559-2562.
150. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993; 73: 309-319.
151. Winberg G, Shenk T. Dissection of overlapping functions within the adenovirus type 5 E1A gene. EMBO J 1984; 3: 1907-1912.
152. Xia D, Henry L, Gerard RD, Deisenhofer J. Structure of the receptor binding domain of adenovirus type 5 fiber protein. Curr Top Microbiol Immunol 1995; 199: 39-46.
153. Xia D, Henry LJ, Gerard RD, Deisenhofer J. Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 A resolution. Structure 1994; 2: 1259-1270.
154. Xu ZZ, Hyatt A, Boyle DB, Both GW. Construction of ovine adenovirus recombinants by gene insertion or deletion of related terminal region sequences. Virology 1997; 230: 62-71.
155. Yang Y, Ertl HC, Wilson JM. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1994; 1: 433-442.
156. Yang Y, Greenough K, Wilson JM. Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver. Gene Ther 1996; 3 412-420.
157. Yang Y, Jooss KU, Su Q, Ertl HC, Wilson JM. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther 1996; 3: 137-144.
158. Yang Y, Li Q, Ertl HC, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995; 69: 2004-2015.
159. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A 1994; 91: 4407-4411.
160. Yang Y, Wilson JM. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J Immunol 1995; 155: 2564-2570.
161. Honda T, Saitoh H, Masuko M, et al. The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain. Brain Res Mol Brain Res 2000; 77: 19-28.
162. Morante-Oria J, Carleton A, Ortino B, Kremer EJ, Fairen A, Lledo PM. Subpallial origin of a population of projecting pioneer neurons during corticogenesis. Proc Natl Acad Sci USA 2003; 100: 12 468-12 473.
163. Kremer Laboratory Website. http://www.igm.cnrs-mop.fr/equipesglobale2.htm. Movies section.
164. Segerman A, Atkinson JP, Marttila M, Dennerquist V, Wadell G, Arnberg. Adenovirus type II uses CD46 as a cellular receptor. J Virol 2003; 77: 9183-9191.